AACR

Biotech By Matthew Herper

Lilly’s Retevmo shows success in rare tumors. But can doctors identify the patients who would be helped?

Biotech By Adam Feuerstein

iTeos Therapeutics debuts first data on TIGIT-targeting cancer immunotherapy

Biotech By Adam Feuerstein

Revolution Medicines seeks to bolster case for its lead cancer drug

Biotech By Damian Garde

Researchers see a ‘tractable approach’ to taming cancer metastasis

Health By Elizabeth Cooney

Early trial shows promise aiming a modified cold-sore virus against brain tumors in children

Biotech By Adam Feuerstein

Natural killer cells, primed with an antibody, induce remissions in patients with advanced blood cancer